The Biotech Academy Awards (The Motley Fool)
Join us on the red carpet.

OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in ... (RedNova)
SAN DIEGO, Feb. 16, 2007 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) today announced findings of a post hoc subgroup analysis of data from its Phase 3 clinical trial of the novel synthetic peptide Chrysalin(R) (TP508) in unstable, displaced distal radius (wrist) fractures.

Advancis Pharmaceutical Announces FDA Decision That its Amoxicillin PULSYS NDA is Not Complete (FinanzNachrichten)
GERMANTOWN, Md., Feb. 13 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation ( Nachrichten ), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that it has received a "refusal to file" letter from the U.S. Food and Drug Administration (FDA) for the Company's once-daily Amoxicillin PULSYS New Drug Application (NDA), ...